ABUS logo

Arbutus Biopharma (ABUS) Long Term Debt

Annual Long Term Debt

$1.34 M
-$472.00 K-26.01%

December 31, 2023


Summary


Performance

ABUS Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABUSbalance sheetmetrics:

Quarterly Long Term Debt

$978.00 K
-$166.00 K-14.51%

September 30, 2024


Summary


Performance

ABUS Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABUSbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

ABUS Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-26.0%0.0%
3 y3 years-48.2%-46.1%
5 y5 years+100.0%-46.1%

ABUS Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-39.8%at low-56.2%at low
5 y5-year-55.5%at low-67.6%at low
alltimeall time-88.8%-100.0%-91.8%-100.0%

Arbutus Biopharma Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$978.00 K(-14.5%)
Jun 2024
-
$1.14 M(-3.1%)
Mar 2024
-
$1.18 M(-12.1%)
Dec 2023
$1.34 M(-26.0%)
$1.34 M(-10.3%)
Sep 2023
-
$1.50 M(-9.1%)
Jun 2023
-
$1.65 M(-1.5%)
Mar 2023
-
$1.67 M(-7.9%)
Dec 2022
$1.81 M(-18.6%)
$1.81 M(-7.2%)
Sep 2022
-
$1.96 M(-6.4%)
Jun 2022
-
$2.09 M(-0.6%)
Mar 2022
-
$2.10 M(-5.9%)
Dec 2021
$2.23 M(-14.0%)
$2.23 M(-5.3%)
Sep 2021
-
$2.35 M(-4.8%)
Jun 2021
-
$2.48 M(-0.1%)
Mar 2021
-
$2.48 M(-4.5%)
Dec 2020
$2.59 M(-14.1%)
$2.59 M(-5.1%)
Sep 2020
-
$2.73 M(-4.7%)
Jun 2020
-
$2.87 M(-0.7%)
Mar 2020
-
$2.89 M(-4.3%)
DateAnnualQuarterly
Dec 2019
$3.02 M(>+9900.0%)
$3.02 M(-4.0%)
Sep 2019
-
$3.14 M(-3.7%)
Jun 2019
-
$3.26 M(-0.3%)
Mar 2019
-
$3.27 M(>+9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2017
$12.00 M(0.0%)
$12.00 M(0.0%)
Sep 2017
-
$12.00 M(0.0%)
Jun 2017
-
$12.00 M(0.0%)
Mar 2017
-
$12.00 M(0.0%)
Dec 2016
$12.00 M(>+9900.0%)
$12.00 M(>+9900.0%)
Sep 2007
-
$13.20 K(-55.9%)
Jun 2007
-
$29.90 K
Dec 2006
$65.00 K(-24.0%)
-
Dec 2005
$85.50 K(-91.4%)
-
Dec 2004
$999.50 K(+23.9%)
-
Dec 2003
$806.60 K(+239.6%)
-
Dec 2001
$237.50 K(+221.4%)
-
Dec 2000
$73.90 K(+16.6%)
-
Dec 1999
$63.40 K(>+9900.0%)
-
Dec 1998
$0.00
-

FAQ

  • What is Arbutus Biopharma annual long term debt?
  • What is the all time high annual long term debt for Arbutus Biopharma?
  • What is Arbutus Biopharma annual long term debt year-on-year change?
  • What is Arbutus Biopharma quarterly long term debt?
  • What is the all time high quarterly long term debt for Arbutus Biopharma?
  • What is Arbutus Biopharma quarterly long term debt year-on-year change?

What is Arbutus Biopharma annual long term debt?

The current annual long term debt of ABUS is $1.34 M

What is the all time high annual long term debt for Arbutus Biopharma?

Arbutus Biopharma all-time high annual long term debt is $12.00 M

What is Arbutus Biopharma annual long term debt year-on-year change?

Over the past year, ABUS annual long term debt has changed by -$472.00 K (-26.01%)

What is Arbutus Biopharma quarterly long term debt?

The current quarterly long term debt of ABUS is $978.00 K

What is the all time high quarterly long term debt for Arbutus Biopharma?

Arbutus Biopharma all-time high quarterly long term debt is $12.00 M

What is Arbutus Biopharma quarterly long term debt year-on-year change?

Over the past year, ABUS quarterly long term debt has changed by $0.00 (0.00%)